Masthead Google Plus Twitter YouTube Facebook On-line Bill Pay

Custom Search
ADVERTISEMENT
Gas Buddy
Ag Info
Today's Health Headlines
The use of gene editing technologies to alter the DNA of human embryos could be morally permissible as long as the science and its impact on society is carefully considered, a British ethics panel said on Tuesday.

Yes, it's harder to sleep in the hospital
Mon, 16 Jul 2018 18:21:29 -0400
(Reuters Health) - Hospital patients get a lot less sleep, wake up more frequently during the night, and rise earlier in the morning than they would in bed at home, a Dutch study suggests.

(Reuters Health) - While most adults know nicotine is bad for children, smokers and some other individuals aren't convinced of this fact, according to a U.S. study that suggests a need for more public education about the risks of tobacco.

(Reuters Health) - Patients with common colds and respiratory illnesses may be more likely to get antibiotics - which don't work for these conditions - when they go to an urgent care clinic, a U.S. study suggests.

Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells.

Indivior Plc's shares jumped more than 33 percent on Monday after a U.S. court blocked a rival from selling a cheaper copycat of the British drugmaker's bestselling opioid addiction treatment.

The Iowa and Illinois health departments said on Thursday that they were investigating cyclospora infections linked to salads at McDonald Corp's restaurants.

China's new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients, state news agency Xinhua said on Saturday.

A U.S. court has granted Indivior a preliminary injunction blocking India's Dr. Reddy's Laboratories from selling cut-price versions of the British drugmaker's best-selling opioid addiction treatment in the United States, Indivior said on Friday.

Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri.

ENTERTAINMENT NEWS
A Chinese blockbuster hopeful backed by Alibaba Pictures Group and with a reported budget of over $1...
Amid olive trees and plenty of ABBA tunes, the musical world of "Mamma Mia" took over a London theat...
A Republican congressman filmed for Sacha Baron Cohen's satirical television series who appeared to ...
SPORTS NEWS
Circuit of the Americas (COTA) chairman Bobby Epstein believes he has time on his side when it comes...
Tiger Woods says the British Open represents his best chance of winning another major championship, ...
The last five majors have been won by Americans and Justin Rose believes this week's British Open of...
Login to access your Mark Twain Web Mail
Video
loading
FINANCE NEWS
Sovereign investors are facing a tougher environment for dealmaking as rising protectionism threaten...
Investors switched to defensive equities and bonds in the week to July 11 as the U.S. slapped tariff...
(This July 12 story corrects data after Lipper revision on U.S.-based corporate investment-grade bon...